m6A Target Gene Information
General Information of the m6A Target Gene (ID: M6ATAR00453)
Full List of m6A Methylation Regulator of This Target Gene and Corresponding Disease/Drug Response(s)
ZEB1
can be regulated by the following regulator(s), and cause disease/drug response(s). You can browse detail information of regulator(s) or disease/drug response(s).
Browse Regulator
Browse Disease
Heterogeneous nuclear ribonucleoproteins A2/B1 (HNRNPA2B1) [READER]
Representative RNA-seq result indicating the expression of this target gene regulated by HNRNPA2B1 | ||
Cell Line | c2c12 cell line | Mus musculus |
Treatment: HNRNPA2B1 knockout c2c12 cells
Control: WT c2c12 cells
|
GSE152467 | |
Regulation |
|
logFC: -7.64E-01 p-value: 1.43E-05 |
More Results | Click to View More RNA-seq Results |
In total 1 item(s) under this regulator | ||||
Experiment 1 Reporting the m6A Methylation Regulator of This Target Gene | [1] | |||
Response Summary | The RP11/hnRNPA2B1/mRNA complex accelerated the mRNA degradation of two E3 ligases, Siah1 and Fbxo45, and subsequently prevented the proteasomal degradation of Zinc finger E-box-binding homeobox 1 (ZEB1). m6A can regulate the expression of RP11, further, RP11 regulated Siah1-Fbxo45/Zeb1 was involved in the development of Colorectal cancer. | |||
Target Regulation | Up regulation | |||
Responsed Disease | Colorectal cancer | ICD-11: 2B91 | ||
Pathway Response | Proteasome | hsa03050 | ||
Cell Process | Proteasomal degradation | |||
In-vitro Model | DLD-1 | Colon adenocarcinoma | Homo sapiens | CVCL_0248 |
HCT 15 | Colon adenocarcinoma | Homo sapiens | CVCL_0292 | |
HCT 8 | Colon adenocarcinoma | Homo sapiens | CVCL_2478 | |
RKO | Colon carcinoma | Homo sapiens | CVCL_0504 | |
SW480 | Colon adenocarcinoma | Homo sapiens | CVCL_0546 | |
In-vivo Model | HCT-15 RP11 stable overexpression or control cells (2 × 106 per mouse) diluted in 100 uL normal medium + 100 uL Matrigel (BD Biosciences) were subcutaneously injected into immunodeficient mice to investigate tumour growth. | |||
YTH domain-containing family protein 3 (YTHDF3) [READER]
Representative RIP-seq result supporting the interaction between ZEB1 and the regulator | ||
Cell Line | Hela | Homo sapiens |
Regulation | logFC: 1.92E+00 | GSE86214 |
In total 2 item(s) under this regulator | ||||
Experiment 1 Reporting the m6A Methylation Regulator of This Target Gene | [2] | |||
Response Summary | circ_KIAA1429 could accelerate HCC advancement, maintained the expression of Zeb1 through the mechanism of m6A-YTHDF3-Zinc finger E-box-binding homeobox 1 (ZEB1) in hepatocellular carcinoma. | |||
Target Regulation | Up regulation | |||
Responsed Disease | Hepatocellular carcinoma | ICD-11: 2C12.02 | ||
Pathway Response | RNA degradation | hsa03018 | ||
Cell Process | RNA stability | |||
In-vitro Model | BEL-7402 | Endocervical adenocarcinoma | Homo sapiens | CVCL_5492 |
BEL-7404 | Endocervical adenocarcinoma | Homo sapiens | CVCL_6568 | |
Hep-G2 | Hepatoblastoma | Homo sapiens | CVCL_0027 | |
Huh-7 | Adult hepatocellular carcinoma | Homo sapiens | CVCL_0336 | |
L-02 | Endocervical adenocarcinoma | Homo sapiens | CVCL_6926 | |
SMMC-7721 | Endocervical adenocarcinoma | Homo sapiens | CVCL_0534 | |
In-vivo Model | 1 × 107 Bel-7404 cells in 200 uL PBS were injected into the right flank of nude mice. | |||
Experiment 2 Reporting the m6A Methylation Regulator of This Target Gene | [3] | |||
Response Summary | YTHDF3 positively regulated cell migration, invasion, and EMT in triple-negative breast cancer cells. Moreover, Zinc finger E-box-binding homeobox 1 (ZEB1) was identified as a key downstream target for YTHDF3 and YTHDF3 could enhance ZEB1 mRNA stability in an m6A-dependent manner. | |||
Target Regulation | Up regulation | |||
Responsed Disease | Breast cancer | ICD-11: 2C60 | ||
Cell Process | Cell migration | |||
Cell invasion | ||||
Epithelial-mesenchymal transition | ||||
In-vitro Model | MDA-MB-231 | Breast adenocarcinoma | Homo sapiens | CVCL_0062 |
Hs 578T | Invasive breast carcinoma | Homo sapiens | CVCL_0332 | |
HCC1937 | Breast ductal carcinoma | Homo sapiens | CVCL_0290 | |
BT-549 | Invasive breast carcinoma | Homo sapiens | CVCL_1092 | |
Colorectal cancer [ICD-11: 2B91]
In total 1 item(s) under this disease | ||||
Experiment 1 Reporting the m6A-centered Disease Response | [1] | |||
Response Summary | The RP11/hnRNPA2B1/mRNA complex accelerated the mRNA degradation of two E3 ligases, Siah1 and Fbxo45, and subsequently prevented the proteasomal degradation of Zinc finger E-box-binding homeobox 1 (ZEB1). m6A can regulate the expression of RP11, further, RP11 regulated Siah1-Fbxo45/Zeb1 was involved in the development of Colorectal cancer. | |||
Responsed Disease | Colorectal cancer [ICD-11: 2B91] | |||
Target Regulator | Heterogeneous nuclear ribonucleoproteins A2/B1 (HNRNPA2B1) | READER | ||
Target Regulation | Up regulation | |||
Pathway Response | Proteasome | hsa03050 | ||
Cell Process | Proteasomal degradation | |||
In-vitro Model | DLD-1 | Colon adenocarcinoma | Homo sapiens | CVCL_0248 |
HCT 15 | Colon adenocarcinoma | Homo sapiens | CVCL_0292 | |
HCT 8 | Colon adenocarcinoma | Homo sapiens | CVCL_2478 | |
RKO | Colon carcinoma | Homo sapiens | CVCL_0504 | |
SW480 | Colon adenocarcinoma | Homo sapiens | CVCL_0546 | |
In-vivo Model | HCT-15 RP11 stable overexpression or control cells (2 × 106 per mouse) diluted in 100 uL normal medium + 100 uL Matrigel (BD Biosciences) were subcutaneously injected into immunodeficient mice to investigate tumour growth. | |||
Liver cancer [ICD-11: 2C12]
In total 1 item(s) under this disease | ||||
Experiment 1 Reporting the m6A-centered Disease Response | [2] | |||
Response Summary | circ_KIAA1429 could accelerate HCC advancement, maintained the expression of Zeb1 through the mechanism of m6A-YTHDF3-Zinc finger E-box-binding homeobox 1 (ZEB1) in hepatocellular carcinoma. | |||
Responsed Disease | Hepatocellular carcinoma [ICD-11: 2C12.02] | |||
Target Regulator | YTH domain-containing family protein 3 (YTHDF3) | READER | ||
Target Regulation | Up regulation | |||
Pathway Response | RNA degradation | hsa03018 | ||
Cell Process | RNA stability | |||
In-vitro Model | BEL-7402 | Endocervical adenocarcinoma | Homo sapiens | CVCL_5492 |
BEL-7404 | Endocervical adenocarcinoma | Homo sapiens | CVCL_6568 | |
Hep-G2 | Hepatoblastoma | Homo sapiens | CVCL_0027 | |
Huh-7 | Adult hepatocellular carcinoma | Homo sapiens | CVCL_0336 | |
L-02 | Endocervical adenocarcinoma | Homo sapiens | CVCL_6926 | |
SMMC-7721 | Endocervical adenocarcinoma | Homo sapiens | CVCL_0534 | |
In-vivo Model | 1 × 107 Bel-7404 cells in 200 uL PBS were injected into the right flank of nude mice. | |||
Breast cancer [ICD-11: 2C60]
In total 1 item(s) under this disease | ||||
Experiment 1 Reporting the m6A-centered Disease Response | [3] | |||
Response Summary | YTHDF3 positively regulated cell migration, invasion, and EMT in triple-negative breast cancer cells. Moreover, Zinc finger E-box-binding homeobox 1 (ZEB1) was identified as a key downstream target for YTHDF3 and YTHDF3 could enhance ZEB1 mRNA stability in an m6A-dependent manner. | |||
Responsed Disease | Breast cancer [ICD-11: 2C60] | |||
Target Regulator | YTH domain-containing family protein 3 (YTHDF3) | READER | ||
Target Regulation | Up regulation | |||
Cell Process | Cell migration | |||
Cell invasion | ||||
Epithelial-mesenchymal transition | ||||
In-vitro Model | MDA-MB-231 | Breast adenocarcinoma | Homo sapiens | CVCL_0062 |
Hs 578T | Invasive breast carcinoma | Homo sapiens | CVCL_0332 | |
HCC1937 | Breast ductal carcinoma | Homo sapiens | CVCL_0290 | |
BT-549 | Invasive breast carcinoma | Homo sapiens | CVCL_1092 | |
References